Abiraterone acetate structure, CAS 154229-18-2

Abiraterone acetate

CAS Number154229-18-2

Synonyms17-(3-pyridyl)-5,16-androstadien-3beta-acetate; Abiraterone acetate; Zytiga; (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate; (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; Abiraterone (acetate)

Molecular FormulaC26H33NO2

Molecular Weight391.55

Purity98%%

Density1.1±0.1 g/cm3

Boiling Point506.7±50.0 °C at 760 mmHg

Melting Point127-130°C

Flash Point

AppearanceSolid;White to Light yellow to Light orange powder to crystal

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9061543 Purity: 98%%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 154229-18-2 ] Purity: 98%% SDS Specification MoL

Chemical & Physical Properties
CAS Number154229-18-2
Catalog No.2A-9061543
Chinese Name乙酸阿比特龙酯
Synonyms17-(3-pyridyl)-5,16-androstadien-3beta-acetate; Abiraterone acetate; Zytiga; (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate; (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; Abiraterone (acetate)
Molecular FormulaC26H33NO2
Molecular Weight391.55
Purity98%
Density1.1±0.1 g/cm3
Boiling Point506.7±50.0 °C at 760 mmHg
Melting Point127-130°C
AppearanceSolid;White to Light yellow to Light orange powder to crystal
Storage Condition-20°C Freezer
ApplicationAbiraterone acetate is an oral, potent, selective and irreversible inhibitor of CYP17.
HTC2933399090
MDL NumberC26H33NO2
SMILESCC(=O)OC1CCC2(C)C(=CCC3C2CCC2(C)C(c4cccnc4)=CCC32)C1
InChIInChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21?,23?,24?,25-,26+/m0/s1
InChI KeyUVIQSJCZCSLXRZ-UBUQANBQSA-N
MSDSmsds/61543_1_154229_18_2.pdf
Use ofAbiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17. Properties Name abiraterone acetate Synonym More Synonyms Abiraterone Acetate Biological Activity Description Abiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17. Related Catalog Signaling Pathways >> Metabolic Enzyme/Protease >> Cytochrome P450 Research Areas >> Cancer In Vitro Abiraterone (Abi) acetate is an ester prodrug of the anticancer agent Abiraterone, which shows IC50 values of 15 nM and 2.5 nM for the 17,20-lyase and 17α-hydroxylase (CYP17 is a bifunctional enzyme with both 17α-hydroxylase and 17,20-lyase activity). Abiraterone inhibits human 17,20-lyase and 17α-hydroxylase with IC50 of 27 and 30 nM respectively[1]. Significant inhibition of proliferation of the AR-positive prostate cancer cell lines LNCaP and VCaP with doses of Abiraterone ≥5 μM is confirmed[2]. Abiraterone inhibits recombinant human 3βHSD1 and 3βHSD2 activity with competitive Ki values of 2.1 and 8.8 μM. 10 μM Abiraterone is sufficient to completely block synthesis of 5α-dione and DHT in both cell lines.Treatment with Abiraterone significantly inhibited CRPC progression in the robustly growing subset, effectively putting a ceiling on tumor growth over 4 weeks of treatment (P<0.00001)[3]. Cell Assay LNCaP and VCaP cells are seeded in 96-well plates and grown in CSS-supplemented phenol red-free or FBS-supplemented media for 7 days. Cells are treated with Abiraterone (5 μM and 10 μM) at 24 and 96 hours after plating and cell viability is determined on day 7 by adding CellTiter Glo and measuring luminescence[2]. References [1]. Stein MN, et al. Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer. Asian J Androl. 2014 May-Jun;16(3):387-400. [3]. Li R, et al. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer. Clin Cancer Res. 2012 Jul 1;18(13):3571-9. [4]. Lee GT, et al. Intracrine androgen biosynthesis in renal cell carcinoma. Br J Cancer. 2017 Mar 28;116(7):937-943. Chemical & Physical Properties Molecular Formula C26H33NO2 Exact Mass 391.251129 PSA 39.19000 Index of Refraction 1.584 InChIKey UVIQSJCZCSLXRZ-UBUQANBQSA-N Safety Information Signal Word Danger Hazard Statements H360-H372 Precautionary Statements P201-P260-P280-P308 + P313 Target Organs Endocrine system Hazard Codes Xi RIDADR NONH for all modes of transport RTECS BV7992100 HS Code 2933399090 Precursor & DownStream Precursor 10 CAS#:115375-60-5 (3β)-Androsta-5... CAS#:1692-25-7 3-Pyridylboroni... CAS#:108-24-7 Ethanoic anhydride CAS#:154229-19-3 Abiraterone DownStream 1 CAS#:154229-19-3 Abiraterone
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in API & Advanced Intermediates
3-A-HYDROXY PRAVASTATIN SODIUM SALT81093-43-82A-9061523
MORPHINE SULPHATE2A-1530232A-9061524
MORPHINE SULPHATE2A-1530242A-9061525
3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine1262133-64-12A-9061535
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine1262133-66-32A-9061536
2-Amino-6-methylmercaptopurine 1198-47-62A-9063520
MORPHINE57-27-22A-9064388
Atorvastatin110862-48-12A-9064577
Deoxyartemisinin 72826-63-22A-9066024
GefitinibIntermediate 675126-27-92A-9070121
Browse all API & Advanced Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA